0002042814-26-000004.txt : 20260410 0002042814-26-000004.hdr.sgml : 20260410 20260410161511 ACCESSION NUMBER: 0002042814-26-000004 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260410 DATE AS OF CHANGE: 20260410 EFFECTIVENESS DATE: 20260410 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Nascent Pharma Holdings, Inc. CENTRAL INDEX KEY: 0002042814 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122] ORGANIZATION NAME: 07 Trade & Services EIN: 331600116 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-579987 FILM NUMBER: 26855038 BUSINESS ADDRESS: STREET 1: 960 SOUTH BROADWAY, SUITE 118 CITY: HICKSVILLE STATE: NY ZIP: 11081 BUSINESS PHONE: 516-595-9544 MAIL ADDRESS: STREET 1: 960 SOUTH BROADWAY, SUITE 118 CITY: HICKSVILLE STATE: NY ZIP: 11081 D 1 primary_doc.xml X0708 D LIVE 0002042814 Nascent Pharma Holdings, Inc. 44 East End Avenue HICKSVILLE NY NEW YORK 11801 516-595-9544 FLORIDA None None Corporation true 2024 Marco Alfonsi 44 East End Avenue 44 East End Avenue HICKSVILLE NY NEW YORK 11801 Executive Officer Director Stanley Teeple 2462 Ping Drive Henderson NV NEVADA 89074 Executive Officer Director Frederick Alger Boyer 1210 Lone Wolf Trail Carrollton TX TEXAS 75007 Director Other No Revenues 06b false 2026-03-12 false true true true true Revenue Sharing Agreement (Investment Contract) false 25000 3000000 75000 2925000 false 2 0 0 750000 true A portion of proceeds may be used to reimburse officers for out-of-pocket expenses and pay accrued compensation. false Nascent Pharma Holdings, Inc. /s/Marco Alfonsi Marco Alfonsi CEO 2026-04-10